Martin Vogelbaum, Director at Cara Therapeutics, Inc. (CARA), sold 10,800 shares at $10.28 ($111K) on 2022-09-14, disclosed to the SEC on 2022-09-16.
Open-market sale of $111k CARA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CARA | BUY | 2016-03-18 | $3.9M | — | Filing → |
| CARA | BUY | 2014-02-05 | $2.5M | — | Filing → |